Sanofi

President Barack Obama convenes a meeting on the Zika virus, in the Situation Room of the White House, Jan. 26, 2016. (Official White House Photo by Pete Souza)

Pharma, US Gov’t pushing for Zika vaccine

By Melissa Fassbender

Sanofi Pasteur has launched a Zika vaccine project, levering its experience in developing vaccines for similar viruses, as the US government pushes for “intensified research.”

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

By Fiona BARRY

The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.

Research consortium looks to identify biomarkers for autism treatments

Research consortium looks to identify biomarkers for autism treatments

By Zachary Brennan

A new four-year research project involving a consortium of government, non-profit and other large biopharma partners is aiming to create a set of measures that can be used in clinical trials to determine which ASD (autism spectrum disorder) treatments...

Sanofi, Schrödinger forge up to $120m drug discovery deal

Sanofi, Schrödinger forge up to $120m drug discovery deal

By Zachary Brennan

Computational drug designer Schrödinger has entered into a five-year early drug discovery collaboration with Sanofi in which Schrödinger will provide target analysis and validation to lead identification and lead optimization for as many as ten drug discovery...

Sanofi signs CRO Evotec to €250m, five-year research partnership

Sanofi signs CRO Evotec to €250m, five-year research partnership

By Zachary Brennan

The strategic partnership comes with Sanofi providing €250m to Evotec, including €40m upfront, as part of efforts to discover new drug candidates, including in the area of oncology, and specifically at Sanofi’s R&D site in Toulouse, France.